SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences - Quaterly Results

09 Feb 2024 Evaluate
The revenue for the December 2023 quarter is pegged at Rs. 1856.07 millions, about 7.48% up against Rs. 1726.88 millions recorded during the year-ago period.The Net Loss for the quarter ended December 2023 is Rs. -116.40 millions as compared to Net Profit of Rs. 157.93 millions of corresponding quarter ended December 2022Operating profit for the quarter ended December 2023 decreased to 80.14 millions as compared to 385.33 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1856.07 1726.88 7.48 5529.33 5712.77 -3.21 7894.36 6855.08 15.16
Other Income 21.26 110.17 -80.70 137.72 358.50 -61.58 288.32 187.04 54.15
PBIDT 80.14 385.33 -79.20 634.72 1106.20 -42.62 1563.90 961.87 62.59
Interest 133.01 116.52 14.15 378.15 333.24 13.48 569.42 334.27 70.35
PBDT -52.87 268.81 -119.67 256.57 772.96 -66.81 994.48 627.60 58.46
Depreciation 124.01 75.37 64.53 366.07 221.04 65.61 328.21 266.83 23.00
PBT -176.88 193.44 -191.44 -109.50 551.92 -119.84 666.27 360.77 84.68
TAX -60.48 35.51 -270.32 -36.34 154.40 -123.54 190.71 102.08 86.82
Deferred Tax -47.17 -1.23 3734.96 -42.62 45.50 -193.67 51.51 38.09 35.23
PAT -116.40 157.93 -173.70 -73.16 397.52 -118.40 475.56 258.69 83.83
Equity 167.46 157.08 6.61 167.46 157.08 6.61 157.09 156.98 0.07
PBIDTM(%) 4.32 22.31 -80.65 11.48 19.36 -40.72 19.81 14.03 41.18

Camlin Fine Sciences Share Price

131.85 4.88 (3.84%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3651.95
Tata Chemicals 804.85
SRF 2551.40
Pidilite Inds. 1364.45
Deepak Nitrite 1751.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×